While it may be accepted as a truism that remedies marketed under fancy proprietary names too often are not what they pretend to be and do not accomplish what they claim, it must not be lightly assumed that the converse is equally true. The physician is rightly suspicious of such products; but on the other hand he should not take it for granted that because a drug bears the name of a definite chemical compound, it is true to name and pure, and therefore trustworthy in its actions. Of this fact we have recent demonstration in respect to emetin. The use of this drug has greatly increased, during the last two or three years, owing to its extensive employment in pyorrhea alveolaris and in amebic dysentery. Furthermore, it is being used by certain mail-order "pyorrhea cure" quacks. It is administered in quantities not far removed from the subtoxic dose, while,
EMETIN: A NOTE OF WARNING. JAMA. 1916;LXVI(17):1310–1311. doi:10.1001/jama.1916.02580430028014
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: